Table of Contents Table of Contents
Previous Page  1243 / 1631 Next Page
Information
Show Menu
Previous Page 1243 / 1631 Next Page
Page Background

Ibrutinib in B-cell lymphoma

Advani R H et al. JCO 2013;31:88-94

Responders (n/N)

Mantle cell

7/9

CLL/SLL

11/16

FL

6/16

DLBCL

2/7

WM

3/4

ORR

60%

N=56. Median 3 (1-10) prior

therapies

1 … 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 … 1631  FlippingBook